期刊
EUROPEAN JOURNAL OF IMMUNOLOGY
卷 38, 期 11, 页码 2957-2961出版社
WILEY-BLACKWELL
DOI: 10.1002/eji.200838833
关键词
Co-activation; Immune escape; Immunotherapy; NK cells; NKG2D
类别
资金
- Swedish Foundation for Strategic Research, Research Council, and Cancer Society
Evidence for increased tumor incidence in NKG2D-deficient mice has set NKG2D as the first innate immune receptor implicated in immuno-surveillance of tumors. In this viewpoint article, we discuss recent genetic insight into NKG2D-mediated suppression of spontaneous tumor development in the context of NKG2D signaling properties. Moreover, we identify unresolved issues and consider how an understanding of NKG2D-receptor and -ligand biology can facilitate successful therapeutic intervention of human cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据